In our investigation, the mean levels of FGF-21 and HOMA-IR were significantly higher, while those of QUICKI were significantly lower in people with T2DM with NAFLD compared with those without NAFLD. The gene discussed is FGF21; the disease is metabolic dysfunction-associated steatotic liver disease.